SBIR Phase III: Strategic Sole-Source Contracting Mechanics

Defining the Phase III Pathway

SBIR Phase III is not a grant; it is the commercialization stage where SBIR-funded technology transitions into a federal contract, licensing deal, or product sale. As outlined by the DOE Office of Science, Phase III work must derive from, extend, or complete the effort performed in Phase I or II. The primary strategic advantage of Phase III is the ability to utilize sole-source procurement authority, which allows agencies to bypass full and open competition for technologies that have already been vetted through the competitive SBIR process.

Leveraging Sole-Source Authority

For BD executives and capture managers, the sole-source nature of Phase III is a powerful tool for mission growth. Because the competition requirement is satisfied by the initial Phase I/II award, agencies can award Phase III contracts directly to the small business. This significantly reduces the procurement timeline and provides a clear path for scaling dual-use technologies into operational federal programs.

Commercialization and Follow-on Investment

Successful commercialization often requires a blend of federal contracts and private investment. According to Grantsights, agencies like the NSF look for revenue from commercial sales, follow-on venture capital, and strategic licensing deals. Contractors should focus on the following metrics to demonstrate readiness for Phase III:

• Technology Readiness Level (TRL): Ensuring the innovation is mature enough for deployment.
• Customer Discovery: Aligning the technology with specific agency mission needs.
• Contractual Alignment: Ensuring the Phase III scope is clearly linked to the original SBIR/STTR research.

| Phase | Focus | Procurement Mechanism | |---|---|---| | Phase I | Feasibility | Competitive Grant | | Phase II | R&D/Prototyping | Competitive Grant | | Phase III | Commercialization | Sole-Source Contract |